Hepion Pharmaceuticals Quote - HEPA

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.499899

Bid

0.485

Ask

0.50

Volume

13,491

0.48 Day's Range 0.51

0.4777 52 Week Range 3.72

Market Cap

3.478M

Previous Close

0.49

Open

0.51

Last Trade

2000

0.499899

Last Trade Time

14:10:27

Financial Volume

US$ 6,775

VWAP

0.502164

Average Volume (3m)

45,285

Shares Outstanding

6,958,371

Dividend Yield

PE Ratio

-0.07

Earnings Per Share (EPS)

-7.03

Revenue

Net Profit

-48.93M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hepion.com

Headquarters

Wilmington, Delaware, USA

Founded

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.49. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.4777 to US$ 3.72.

Hepion Pharmaceuticals currently has 6,958,371 shares outstanding. The market capitalization of Hepion Pharmaceuticals is US$3.41 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.07.

Form 8-K - Current report

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Form 425 - Prospectuses and communications, business combinations

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.080101	-13.8105172414	0.58	0.599	0.48	29376	0.52184412	CS
4	-0.190101	-27.5508695652	0.69	0.715	0.4777	28683	0.59097191	CS
12	-0.220101	-30.5695833333	0.72	0.89	0.4777	45285	0.68728092	CS
26	-0.496001	-49.8042976202	0.9959	1.12	0.4777	98906	0.79342626	CS
52	-2.720101	-84.4751863354	3.22	3.72	0.4777	79216	1.27070879	CS
156	-26.300101	-98.1347052239	26.8	27.2	0.4777	222765	14.00649807	CS
260	-99.700101	-99.5010988024	100.2	150	0.4777	905610	40.96852626	CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?

The current share price of Hepion Pharmaceuticals is US$ 0.499899

How many Hepion Pharmaceuticals shares are in issue?

Hepion Pharmaceuticals has 6,958,371 shares in issue

What is the market cap of Hepion Pharmaceuticals?

The market capitalisation of Hepion Pharmaceuticals is USD 3.41M

What is the 1 year trading range for Hepion Pharmaceuticals share price?

Hepion Pharmaceuticals has traded in the range of US$ 0.4777 to US$ 3.72 during the past year

What is the PE ratio of Hepion Pharmaceuticals?

The price to earnings ratio of Hepion Pharmaceuticals is -0.07

What is the reporting currency for Hepion Pharmaceuticals?

Hepion Pharmaceuticals reports financial results in USD

What is the latest annual profit for Hepion Pharmaceuticals?

The latest annual profit of Hepion Pharmaceuticals is USD -48.93M

What is the registered address of Hepion Pharmaceuticals?

The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Hepion Pharmaceuticals website address?

The website address for Hepion Pharmaceuticals is www.hepion.com

Which industry sector does Hepion Pharmaceuticals operate in?

Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DRCTDirect Digital Holdings Inc	US$ 4.06 (638.18%)	53.8M
CHEKCheck Cap Ltd	US$ 2.07 (250.85%)	31.67M
TRAWTraws Pharma Inc	US$ 12.90 (156.97%)	27.28M
SLGLSol Gel Technologies Ltd	US$ 1.10 (156.41%)	6.27M
RELIReliance Global Group Inc	US$ 3.00 (150.00%)	102.81M
AILEiLearningEngines Inc	US$ 0.2101 (-76.26%)	20.78M
MGOLMGO Global Inc	US$ 0.4489 (-52.75%)	13.17M
YHCLQR House Inc	US$ 1.105 (-36.86%)	1.21M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.3998 (-34.63%)	165.24M
MOBXMobix Labs Inc	US$ 1.26 (-32.62%)	1.53M
EDBLEdible Garden AG Inc	US$ 0.347201 (46.07%)	398.04M
RGTIRigetti Computing Inc	US$ 10.70 (14.19%)	217.44M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.3998 (-34.63%)	168.3M
RIMEAlgorhythm Holdings Inc	US$ 0.093 (21.73%)	139.27M
NVDANVIDIA Corporation	US$ 138.92 (3.13%)	138.72M